Neue Endotypen in Typ-1-Diabetes
Katsiaryna Prystupa(Deutsches Diabetes-Zentrum e.V.), Róbert Wágner(Düsseldorf University Hospital), Michael Roden(Düsseldorf University Hospital), Sebastian M. Meyhöfer, Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), Julia Szendrödi(Heidelberg University), Klaus Straßburger(Deutsches Diabetes-Zentrum e.V.), Michael Stümvoll(University Hospital Leipzig), Andreas Fritsche(Deutsches Diabetes-Zentrum e.V.), Oana‐Patricia Zaharia(Düsseldorf University Hospital), Volker Burkart(Deutsches Diabetes-Zentrum e.V.), Andreas Pfeiffer(Helmholtz Zentrum München), Gidon J. Bönhof(Paderborn University), Alexander Strom(Deutsches Diabetes-Zentrum e.V.), Martin Heni(University Hospital Ulm), Nina Saatmann(Deutsches Diabetes-Zentrum e.V.), Jochen Seißler
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
|Diabetes|2003|1.5k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k